DeepMind just won the Nobel Prize for solving protein folding with AlphaFold. More interesting: they gave away 214 million protein structures for free, then turned around and signed $3 billion in pharma deals. Here's how the technical breakthrough works, why the business model is genius, and what opportunities

Voyager Therapeutics, a clinical-stage biotechnology company, is making remarkable strides in the field of neurogenetic medicine. Specializing in gene therapy to address neurological diseases, Voyager is on a mission to leverage human genetics to modify the course of these debilitating conditions and ultimately provide cures. The company’s innovative approaches